Salem Investment Counselors’s NovoCure NVCR Stock Holding History

Salem Investment Counselors’s Portfolio NVCR Stock Details NVCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$31	Hold	2	–	–	﹤0.01%	1231
2026 Q1	$22	Buy	+2	New	+$25	﹤0.01%	1229
2024 Q3	–	Sell	-4	Closed	-$69	–	1216
2024 Q2	$69	Hold	4	–	–	﹤0.01%	1151
2024 Q1	$63	Hold	4	–	–	﹤0.01%	1157
2023 Q4	$60	Hold	4	–	–	﹤0.01%	1097
2023 Q3	$65	Sell	4 -85	-96%	-$2.45K	﹤0.01%	1088
2023 Q2	$3.69K	Buy	89 +10	+13%	+$621	﹤0.01%	950
2023 Q1	$4.75K	Hold	79	–	–	﹤0.01%	915
2022 Q4	$5.79K	Hold	79	–	–	﹤0.01%	865
2022 Q3	$6K	Hold	79	–	–	﹤0.01%	846
2022 Q2	$5K	Hold	79	–	–	﹤0.01%	886
2022 Q1	$7K	Hold	79	–	–	﹤0.01%	812
2021 Q4	$6K	Buy	79 +4	+5%	+$402	﹤0.01%	908
2021 Q3	$9K	Hold	75	–	–	﹤0.01%	783
2021 Q2	$17K	Hold	75	–	–	﹤0.01%	648
2021 Q1	$10K	Hold	75	–	–	﹤0.01%	676
2020 Q4	$13K	Hold	75	–	–	﹤0.01%	622
2020 Q3	$8K	Buy	+75	New	+$6K	﹤0.01%	578

Other funds holding NVCR

Burney Company Reston, Virginia $3.71B AUM 37.66% 1-Year Est. Return

CMF

Counterpoint Mutual Funds San Diego, California $1.01B AUM 37.65% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

STRS Ohio Columbus, Ohio $26.7B AUM 43.32% 1-Year Est. Return

HWAM

Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return

ETC

Exchange Traded Concepts Oklahoma City, Oklahoma $21.9B AUM 68.6% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

CPIG

Chicago Partners Investment Group Chicago, Illinois $5B AUM 26.84% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

PFSRSONJ

Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

Salem Investment Counselors's NVCR Position: Q2 2026 in Review

Salem Investment Counselors held its NovoCure (NVCR) position steady in Q2 2026 at 2 shares worth $31. The position accounts for ﹤0.01% of the portfolio, ranked #1231.

Salem Investment Counselors first reported a position in NVCR in Q3 2020 and has held it in 18 quarters since. The position peaked at $17K in Q2 2021. 42 funds tracked by Wall St. Rank hold NVCR as of Q2 2026.

Salem Investment Counselors held 2 shares of NovoCure worth $31 as of Q2 2026.
Salem Investment Counselors left its NovoCure share count unchanged in Q2 2026.
NovoCure made up ﹤0.01% of Salem Investment Counselors's portfolio in Q2 2026, its #1231 holding.
Salem Investment Counselors first reported a position in NovoCure in Q3 2020 and has held it in 18 quarters since.
Salem Investment Counselors's NovoCure position peaked at $17K in Q2 2021.
42 funds tracked by Wall St. Rank held NovoCure as of Q2 2026.

Based on Salem Investment Counselors's 13F filing for Q2 2026, filed 14 Jul 2026.